Brintellix Review To Focus On Cognitive Function Measurement
This article was originally published in The Pink Sheet Daily
Executive Summary
Takeda's request for novel claim for an antidepressant hinges on FDA acceptance of clinical outcomes assessment used in vortioxetine's trials, but agency raises doubts about utility of results.